Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Bladder Cancer Using Urinary Cell-free DNA and Cellular DNA

NCT03066310 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT03066310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03066310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Bladder Cancer Using Urinary Cell-free DNA and Cellular DNA
Lead sponsor
Xiangya Hospital of Central South University
Phase
Observational
Overall status
Completed
Start date
January 17, 2017
Completion date
January 10, 2020
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker, bladder cancer, diagnosis, urine